| All patients n = 144 | Non-sepsis n = 44 | Sepsis n = 100 | p value |
---|---|---|---|---|
Sex (male/female) | 88/56 | 27/17 | 61/39 | ns |
Age, years (mean ± SD) | 58 ± 17.5 | 57.5 ± 20.1 | 58.3 ± 16 | 0.907 |
SAPS II, median (IQR) | 47 (33–62) | 44 (27–60) | 48 (36–64) | 0.176 |
SOFA, median (IQR) | 8 (6–11) | 6 (4–10) | 8 (6–11) | 0.008 |
Creatininemia, median (IQR), (μmol/L) | 68 (27–102) | 80 (29–107) | 57 (26–101) | 0.419 |
hsCRP, median (IQR), (mg/L) | 108 (38–133) | 31 (5–87) | 180 (81–284) | <0.0001 |
PCT, median (IQR), (ng/mL) | 1.89 (0.32–13.7) | 0.3 (0.1–0.9) | 4.7 (0.8–20.5) | <0.0001 |
Presepsin, median (IQR), (pg/mL) | 1058 (510–2090) | 454 (315–915) | 1432 (773–2337) | <0.0001 |
ICU length of stay (IQR), (days) | 4 (2–10) | 3 (1–7) | 5 (2–11) | 0.04 |
ICU mortality, n (%) | 34 (23.6) | 9 (20.4) | 25 (25) | ns |
In-hospital mortality, n (%) | 38 (26.3) | 10 (22.7) | 28 (28) | ns |